<DOC>
	<DOCNO>NCT00748904</DOCNO>
	<brief_summary>The purpose study evaluate patient cirrhosis liver renal failure determine administration rifaximin compare lactulose associate less frequent and/or slow progression severe hepatic encephalopathy . If one associate low blood ammonia level . And , one associate low breath hydrogen methane level .</brief_summary>
	<brief_title>Rifaximin Versus Lactulose Renal Failure</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Rifaximin</mesh_term>
	<mesh_term>Lactulose</mesh_term>
	<mesh_term>Rifamycins</mesh_term>
	<criteria>cirrhosis liver etiology progressive renal failure stage 02 hepatic encephalopathy pregnant woman</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>cirrhosis liver progressive renal failure</keyword>
</DOC>